Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

This phase II/III trial studies how well methylphenidate and exercise work in reducing
cancer-related fatigue in patients with prostate cancer. Methylphenidate is a type of central
nervous system stimulant that can improve cognitive ability, mainly in memory and cognitive
function. Exercise can improve mood and the physical aspects of cancer-related fatigue.
Giving methylphenidate in combination with exercise may work better in reducing
cancer-related fatigue in patients with prostate cancer.

Intervention

Exercise Intervention, Methylphenidate, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Stretching

Condition

Prostate Carcinoma

Investigators

Sriram Yennu

See list of participating sites